COM-B | TDF Domain | Codes | Barrier or Facilitator | |
---|---|---|---|---|
Capability | Psychological | Knowledge | Interactions with disease, drugs and foods can be barriers to using medication (biological mechanisms) | Barrier |
Severity of agitation can be a barrier to the use of some medications | Barrier | |||
Lack of education among friend and family caregivers on drug approaches for agitation and aggression | Barrier | |||
Lack of non-pharmacological interventions available for agitation or aggression | Barrier | |||
Lack of training specifically for non-pharmacological treatment approaches among LTC staff | Barrier | |||
Needing to use trial and error to choose non-pharmacological approach | Barrier | |||
Gentle Persuasion Approach taught among staff | Facilitator | |||
Specifically assessing basic needs as first line non-pharmacological treatment | Facilitator | |||
Ensuring staff have the competence and training to administer non-pharmacological treatment approaches | Facilitator | |||
Non-pharmacological interventions are only administered by nursing staff, not physicians, thus barriers to use are not known by physicians | Barrier | |||
Best treatment approach is dependent on the person (drug vs. non-drug) | Facilitator | |||
 |  | Cognitive and Interpersonal skills | Agitation symptoms are too severe (e.g. safety concerns) limiting non-pharmacological interventions but permitting pharmacological interventions | Barrier/ Facilitator |
Lack of non-pharmacological interventions available for agitation or aggression | Barrier | |||
Lack of training specifically for non-pharmacological treatment approaches among LTC staff | Barrier | |||
Needing to use trial and error to choose non-pharmacological approach choose non-pharmacological approach | Barrier | |||
Gentle Persuasion Approach taught among staff | Facilitator | |||
Specifically assessing basic needs as first line non-pharmacological treatment | Facilitator | |||
Ensuring staff have the competence and training to administer non-pharmacological treatment approaches | Facilitator | |||
Treatment for agitation depends on the confidence and education of staff to administer non-pharmacological interventions | Facilitator | |||
Use of medication because it helps address agitated behaviours related to dementia | Facilitator | |||
Staff are afraid to use non-pharmacological interventions | Barrier | |||
IM administration route eases ability to administer medication | Facilitator | |||
Best treatment approach is dependent on the person (drug vs. non-drug) | Facilitator | |||
 |  | Memory, Attention and Decision Making Processes | Comorbid neuropsychiatric diagnosis can conflict with treating agitation symptoms | Barrier |
Difficulty coordinating timing for intervention among a group of residents (E.g. reluctance to participate in non-pharmacological activities) | Barrier | |||
Advancement in dementia results in frequent changes in non-pharmacological treatment plan needed | Barrier | |||
Loss of personal traits or skills after administering medication for agitation | Barrier | |||
 |  | Behavioural Regulation | Overuse of restraints | Barrier |
Having non-pharmacological options available such as verbal de-escalation, wait and re-approach, and redirection can be critical for acute or severe agitation | Facilitator | |||
Agitation symptoms are too severe (e.g. safety concerns) limiting non-pharmacological interventions but permitting pharmacological interventions | Barrier/ Facilitator | |||
Using chemical restraints (i.e. medications) because agitation symptoms do not respond to other interventions | Facilitator | |||
Acute/severe agitation can warrant emergency services | Barrier | |||
Challenges in physically administering medication (e.g.; medication administration can be traumatizing for a person with dementia) | Barrier | |||
Comorbid neuropsychiatric diagnosis can conflict with treating agitation symptoms | Barrier | |||
Poor response or worsening of behaviour when medications were used | Barrier | |||
Reliance on medications | Barrier | |||
Adverse side effects of medications | Barrier | |||
Use of Medication because it is convenient | Barrier | |||
Not all types of agitation are responsive to medications | Barrier | |||
Routine monitoring of non-pharmacological approaches | Facilitator | |||
Routine monitoring of medications | Facilitator | |||
Positive outcomes from non-pharmacological treatments for agitation | Facilitator | |||
Use of medication because it helps address agitated behaviours related to dementia | Facilitator | |||
IM administration route eases ability to administer medication | Facilitator | |||
Using documentation to monitor interventions | Facilitator | |||
Some residents do respond well to medications for agitation and/or aggression | Facilitator | |||
Ensuring plans are in place to reassess residents to potentially deprescribe medication | Facilitator | |||
 | Physical | Physical Skills | - | - |
Opportunity | Social | Social influences | Drug shortages and availability can be a barrier to the use of some medications | Barrier |
Challenges in identifying side effects from the drugs | Barrier | |||
Challenges in monitoring medications (i.e. no monitoring of medications) | Barrier | |||
Lack of non-pharmacological interventions available for agitation or aggression | Barrier | |||
Difficulty coordinating timing for intervention among a group of residents (E.g. reluctance to participate in non-pharmacological activities) | Barrier | |||
Advancement in dementia results in frequent changes in non-pharmacological treatment plan needed | Barrier | |||
Easy to access prescriptions for agitation medications | Barrier/Facilitator | |||
Use of Medication Because it is convenient | Barrier | |||
Staff pressures on physicians to move to medication sooner | Barrier | |||
Resources are available that support the use of non-pharmacological interventions (e.g. geriatric mental health) | Facilitator | |||
 | Physical | Environmental Context and Resources | Drug shortages and availability can be a barrier to the use of some medications | Barrier |
Challenges in identifying side effects from the drugs | Barrier | |||
Challenges in monitoring medications (i.e. no monitoring of medications) | Barrier | |||
Challenges in physically administering medication (e.g.; medication administration can be traumatizing for a person with dementia) | Barrier | |||
Lack of non-pharmacological interventions available for agitation or aggression | Barrier | |||
Difficulty coordinating timing for intervention among a group of residents (E.g. reluctance to participate in non-pharmacological activities) | Barrier | |||
Advancement in dementia results in frequent changes in non-pharmacological treatment plan needed | Barrier | |||
Use of Medication because it is convenient | Barrier | |||
Not all types of agitation are responsive to medications | Barrier | |||
Easy to access prescriptions for agitation medications | Barrier/Facilitator | |||
Lack of sensory experience non-pharmacological approaches | Barrier | |||
Intentional use of non-pharmacological treatment strategies | Facilitator | |||
No regular guidelines to use restraints for agitated patients | Facilitator | |||
Takes time to acquire consent for a mechanical restraint | Barrier | |||
Staff pressures on physicians to move to medication sooner | Barrier | |||
Resources are available that support the use of non-pharmacological interventions (e.g. geriatric mental health) | Facilitator | |||
Motivation | Reflective | Social/Professional Role and Identity | Lack of education among friend and family caregivers on drug approaches for agitation and aggression | Barrier |
Having familiar and developing trust with healthcare providers each time to administer non-pharmacological support for residents | Facilitator | |||
Although doctors prescribe, the whole interdisciplinary team reports on the effectiveness of treatments | Facilitator | |||
Takes time to acquire consent for a mechanical restraint | Barrier | |||
Staff are afraid to use non-pharmacological interventions | Barrier | |||
Non-pharmacological interventions are only administered by nursing staff, not physicians, thus barriers to use are not known by physicians | Barrier | |||
Staff pressures on physicians to move to medication sooner | Barrier | |||
Families or caregivers may not want medications used for the resident | Barrier | |||
 |  | Beliefs about capabilities | Interactions with disease, drugs and foods can be barriers to using medication (biological mechanisms) | Barrier |
Severity of agitation can be a barrier to the use of some medications | Barrier | |||
Challenges in identifying side effects from the drugs | Barrier | |||
Challenges in monitoring medications (i.e. no monitoring of medications) | Barrier | |||
Choosing non-pharmacological approaches as first line | Facilitator | |||
Ensuring staff have the competence and training to administer non-pharmacological treatment approaches | Facilitator | |||
Staff are afraid to use non-pharmacological interventions | Barrier | |||
 |  | Optimism | Seeing the patient improve with medication (E.g. making patients more content) | Facilitator |
Positive outcomes from non-pharmacological treatments for agitation | Facilitator | |||
Choosing non-pharmacological approaches as first line | Facilitator | |||
Treatment for agitation depends on the confidence and education of staff to administer non-pharmacological interventions | Facilitator | |||
Some residents do respond well to medications for agitation and/or aggression | Facilitator | |||
 |  | Beliefs about Consequences | Agitation symptoms are too severe (e.g. safety concerns) limiting non-pharmacological interventions but permitting pharmacological interventions | Barrier/Facilitator |
Using chemical restraints (i.e. medications) because agitation symptoms do not respond to other interventions | Facilitator | |||
Acute/severe agitation can warrant emergency services | Barrier | |||
Poor response or worsening of behaviour when medications were used | Barrier | |||
Reliance on medications | Barrier | |||
Risk of using non-pharmacological approach (e.g. behaviour does not improve) | Barrier | |||
Adverse side effects of medications | Barrier | |||
Needing to use trial and error to choose non-pharmacological approach | Barrier | |||
Seeing the patient improve with medication (E.g. making patients more content) | Facilitator | |||
Positive outcomes from non-pharmacological treatments for agitation | Facilitator | |||
Choosing non-pharmacological approaches as first line | Facilitator | |||
Specifically assessing basic needs as first line non-pharmacological treatment | Facilitator | |||
Use of medication because it helps address agitated behaviours related to dementia | Facilitator | |||
Inconsistent monitoring of interventions | Barrier | |||
Ensuring plans are in place to reassess residents to potentially deprescribe medication | Facilitator | |||
 |  | Intentions | Agitation symptoms are too severe (e.g. safety concerns) limiting non-pharmacological interventions but permitting pharmacological interventions | Barrier/Facilitator |
Using chemical restraints (i.e. medications) because agitation symptoms do not respond to other interventions | Facilitator | |||
Acute/severe agitation can warrant emergency services | Barrier | |||
Needing to use trial and error to choose non-pharmacological approach | Barrier | |||
Lack of sensory experience non-pharmacological approaches | Barrier | |||
Routine monitoring of non-pharmacological approaches | Facilitator | |||
Routine monitoring of medications | Facilitator | |||
Seeing the patient improve with medication (E.g. making patients more content) | Facilitator | |||
Specifically assessing basic needs as first line non-pharmacological treatment | Facilitator | |||
No regular guidelines to use restraints for agitated patients | Facilitator | |||
IM administration route eases ability to administer medication | Facilitator | |||
Some residents do respond well to medications for agitation and/or aggression | Facilitator | |||
Challenges in monitoring medications (i.e. no monitoring of medications) | Barrier | |||
Best treatment approach is dependent on the person (drug vs. non-drug) | Facilitator | |||
 |  | Goals | Agitation symptoms are too severe (e.g. safety concerns) limiting non-pharmacological interventions but permitting pharmacological interventions | Barrier/Facilitator |
Using chemical restraints (i.e. medications) because agitation symptoms do not respond to other interventions | Facilitator | |||
Needing to use trial and error to choose non-pharmacological approach | Barrier | |||
Lack of sensory experience non-pharmacological approaches | Barrier | |||
Routine monitoring of non-pharmacological approaches | Facilitator | |||
Routine monitoring of medications | Facilitator | |||
Seeing the patient improve with medication (E.g. making patients more content) | Facilitator | |||
Specifically assessing basic needs as first line non-pharmacological treatment | Facilitator | |||
No regular guidelines to use restraints for agitated patients | Facilitator | |||
IM administration route eases ability to administer medication | Facilitator | |||
Best treatment approach is dependent on the person (drug vs. non-drug) | Facilitator | |||
 | Automatic | Reinforcement | Overuse of restraints | Barrier |
Having non-pharmacological options available such as verbal de-escalation, wait and re-approach, and redirection can be critical for acute or severe agitation | Facilitator | |||
Routine monitoring of non-pharmacological approaches | Facilitator | |||
Routine monitoring of medications | Facilitator | |||
Having familiar and developing trust with healthcare providers each time to administer non-pharmacological support for residents | Facilitator | |||
Inconsistent monitoring of interventions | Barrier | |||
Using documentation to monitor interventions | Facilitator | |||
Challenges in monitoring medications (i.e. no monitoring of medications) | Barrier | |||
Ensuring plans are in place to reassess residents to potentially deprescribe medication | Facilitator | |||
 |  | Emotion | Challenges in physically administering medication (e.g.,; medication administration can be traumatizing for a person with dementia) | Barrier |
Comorbid neuropsychiatric diagnosis can conflict with treating agitation symptoms | Barrier | |||
Loss of personal traits or skills after administering medication for agitation | Barrier | |||
Not all types of agitation are responsive to medications | Barrier |